Table 1: Demographic and clinical characteristics of the study population.
| Parameters | Controls | Patients with diabetes | Patients without DR | Patients with NPDR |
|---|---|---|---|---|
| Number of cases (n) | 60 | 60 | 30 | 30 |
| Age (mean ± SD) | 58.77 ± 8.99 | 62.01 ± 11.26 | 59.40 ± 11.63 | 64.63 ± 10.41 |
| Gender (M:F) | 25:35 | 34:26 | 14:16 | 20:10 |
| IOP, mmHg | 15.77 ± 2.68 | 15.65 ± 2.61 | 15.77 ± 2.44 | 15.52 ± 2.81 |
| BCVA | 0.853 ± 0.223 | 0.896 ± 0.191 | 0.938 ± 0.15 | 0.852 ± 0.22 |
| HbA1c (%) | - | 8.22 ± 1.76 | 8.19 ± 2.10 | 8.24 ± 1.38 |
| Duration of diabetes (years) 0-10 11-20 > 20 |
- - - |
37 (61.7%) 15 (25%) 8 (13.3%) |
27 (90%) 2 (6.7%) 1 (3.3%) |
10 (33.3%) 13 (43.3%) 7 (23.3%) |
| Hypertension, n (%) | 19 (32%) | 41 (68%) | 19 (63%) | 22 (73%) |
| Duration of hypertension(years) | 11.36 ± 10.47 | 11.46 ± 9.02 | 10.21 ± 9.59 | 12.54 ± 8.57 |
| Grade of hypertensive retinopathy Grade 1 Grade 2 |
5 (8.3%) 1 (1.7%) |
14 (23.3%) 8 (13.3%) |
8 (26.7%) 3 (10%) |
6 (20%) 5 (16.7%) |
SD: Standart Deviation; M: Male; F: Female; IOP: Intraocular Pressure; BCVA: Best Corrected Visual Acuity;
DR: Diabetic Retinopathy; NPDR: Nonproliferative Diabetic Retinopathy.